Reporting to the Associate Director, Quality Assurance, the Manager II, Quality Assurance, is responsible for the review and processing of manufacturing Deviations and Laboratory OOS, and review of manufacturing-related Change Controls within Tarsus’ established QMS system. This role will also be responsible for authoring Annual Product Reviews, analyzing and trending analytical data, approval of Certificates of Analysis, manufacturing batch record review and product disposition.
Let’s talk about some of the key responsibilities of the role:
Factors for Success:
A Few Other Details Worth Mentioning:
At Tarsus, we understand the importance of attracting and retaining top talent. The expected base pay range for this position is $120,000 - $168,000 plus bonus, stock equity, and comprehensive benefits. The base pay range reflects the target range for this position, but individual pay will be determined by additional factors such as job-related skills, experience and relevant education or training. Our benefits include health, dental and vision insurance benefits to ensure your well-being. We believe in work-life balance and offer generous paid time off, including vacation, holidays, and personal days. For more details regarding Tarsus benefits, please visit: https://eb.alliant.com/26tarsusbenefitssnapshot.
#LI-Hybrid
Tarsus Pharmaceuticals, Inc. is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
At Tarsus, we are looking for inspired individuals who are motivated to grow professionally, while building a best-in-class pharmaceutical company with a differentiated approach. Join us in advancing our mission to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients. Who is Tarsus? We are a biopharmaceutical company focused on the development and commercialization of therapeutic candidates designed to address diseases with high unmet need across therapeutic categories, including eye care and infectious diseases. We are advancing our pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution) 0.25% is FDA-approved in the United States for the treatment of Demodex blepharitis. In addition, we are developing TP-04 for the potential treatment of ocular rosacea and TP-05, an oral tablet for the prevention of Lyme disease. TP-05 is currently being studied in a Phase 2a clinical trial and TP-04 is scheduled to begin a Phase 2 clinical trial in 2025 to evaluate safety, tolerability and proof of activity. If you are looking for an opportunity to work alongside a diverse team with deep expertise, have a curious and driven mindset and a passion for helping patients, then join our Tarsus community and help build our unique culture!
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Quality Assurance (QA) Q&A's